GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jianmin Pharmaceutical Group Co Ltd (SHSE:600976) » Definitions » Cyclically Adjusted Revenue per Share

Jianmin Pharmaceutical Group Co (SHSE:600976) Cyclically Adjusted Revenue per Share : ¥19.03 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Jianmin Pharmaceutical Group Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Jianmin Pharmaceutical Group Co's adjusted revenue per share for the three months ended in Mar. 2024 was ¥6.336. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥19.03 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Jianmin Pharmaceutical Group Co's average Cyclically Adjusted Revenue Growth Rate was 6.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.30% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 6.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Jianmin Pharmaceutical Group Co was 7.80% per year. The lowest was 3.80% per year. And the median was 6.40% per year.

As of today (2024-05-16), Jianmin Pharmaceutical Group Co's current stock price is ¥61.81. Jianmin Pharmaceutical Group Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥19.03. Jianmin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio of today is 3.25.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Jianmin Pharmaceutical Group Co was 4.87. The lowest was 1.00. And the median was 2.28.


Jianmin Pharmaceutical Group Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Jianmin Pharmaceutical Group Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jianmin Pharmaceutical Group Co Cyclically Adjusted Revenue per Share Chart

Jianmin Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.64 14.95 16.19 17.64 18.75

Jianmin Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.85 18.05 18.45 18.75 19.03

Competitive Comparison of Jianmin Pharmaceutical Group Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Jianmin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jianmin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jianmin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Jianmin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio falls into.



Jianmin Pharmaceutical Group Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jianmin Pharmaceutical Group Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=6.336/115.2271*115.2271
=6.336

Current CPI (Mar. 2024) = 115.2271.

Jianmin Pharmaceutical Group Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 2.879 98.200 3.378
201409 2.705 98.900 3.152
201412 2.865 99.000 3.335
201503 3.072 99.900 3.543
201506 3.545 99.500 4.105
201509 3.214 100.500 3.685
201512 5.166 100.600 5.917
201603 4.085 102.200 4.606
201606 3.391 101.400 3.853
201609 3.997 102.400 4.498
201612 3.960 102.600 4.447
201703 3.932 103.200 4.390
201706 5.481 103.100 6.126
201709 4.208 104.100 4.658
201712 3.908 104.500 4.309
201803 3.240 105.300 3.545
201806 3.866 104.900 4.247
201809 3.362 106.600 3.634
201812 3.618 106.500 3.914
201903 3.427 107.700 3.667
201906 3.717 107.700 3.977
201909 4.524 109.800 4.748
201912 2.698 111.200 2.796
202003 2.795 112.300 2.868
202006 3.872 110.400 4.041
202009 3.798 111.700 3.918
202012 5.463 111.500 5.646
202103 5.495 112.662 5.620
202106 6.309 111.769 6.504
202109 5.334 112.215 5.477
202112 4.589 113.108 4.675
202203 6.002 114.335 6.049
202206 6.105 114.558 6.141
202209 6.367 115.339 6.361
202212 5.438 115.116 5.443
202303 6.616 115.116 6.622
202306 7.517 114.558 7.561
202309 6.293 115.339 6.287
202312 7.122 114.781 7.150
202403 6.336 115.227 6.336

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Jianmin Pharmaceutical Group Co  (SHSE:600976) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Jianmin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=61.81/19.03
=3.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Jianmin Pharmaceutical Group Co was 4.87. The lowest was 1.00. And the median was 2.28.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Jianmin Pharmaceutical Group Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Jianmin Pharmaceutical Group Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Jianmin Pharmaceutical Group Co (SHSE:600976) Business Description

Traded in Other Exchanges
N/A
Address
No. 484 Parrot Avenue, Hanyang District, Wuhan, CHN, 430052
Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.

Jianmin Pharmaceutical Group Co (SHSE:600976) Headlines

No Headlines